|
gptkbp:instanceOf
|
gptkb:long-acting_beta2-adrenergic_agonist
gptkb:drug
|
|
gptkbp:approvalYear
|
1998
|
|
gptkbp:ATCCode
|
gptkb:R03AC13
|
|
gptkbp:CASNumber
|
43229-80-7
|
|
gptkbp:chemicalClass
|
gptkb:phenylethanolamine
|
|
gptkbp:contraindication
|
hypersensitivity to formoterol
|
|
gptkbp:discoveredBy
|
gptkb:AstraZeneca
|
|
gptkbp:eliminationHalfLife
|
10 hours
|
|
gptkbp:hasMolecularFormula
|
C42H56N4O14
|
|
gptkbp:isomerOf
|
gptkb:formoterol
|
|
gptkbp:KEGGID
|
D07913
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
beta2-adrenergic receptor agonist
|
|
gptkbp:meltingPoint
|
>200°C
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
DB00983
3083544
CHEMBL1201317
|
|
gptkbp:routeOfAdministration
|
inhalation
|
|
gptkbp:sideEffect
|
headache
tremor
palpitations
muscle cramps
|
|
gptkbp:synonym
|
gptkb:Foradil
gptkb:Oxeze
|
|
gptkbp:UNII
|
K2D2M353FA
|
|
gptkbp:usedFor
|
asthma
chronic obstructive pulmonary disease
|
|
gptkbp:bfsParent
|
gptkb:Bevespi_Aerosphere
gptkb:Duaklir_Pressair
gptkb:Foradil
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
formoterol fumarate
|